FY2020 Earnings Estimate for UnitedHealth Group Inc (UNH) Issued By Svb Leerink
UnitedHealth Group Inc (NYSE:UNH) – Equities researchers at Svb Leerink increased their FY2020 earnings per share (EPS) estimates for UnitedHealth Group in a report released on Wednesday, April 17th. Svb Leerink analyst A. Gupte now anticipates that the healthcare conglomerate will earn $16.98 per share for the year, up from their previous estimate of $16.87. Svb Leerink also issued estimates for UnitedHealth Group’s FY2021 earnings at $19.68 EPS.
UNH has been the topic of a number of other research reports. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 19th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $300.00 to $305.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 16th. ValuEngine cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, February 27th. Cantor Fitzgerald reissued a “buy” rating and set a $310.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, January 15th. Finally, Stephens started coverage on shares of UnitedHealth Group in a research report on Monday, January 14th. They set an “overweight” rating and a $287.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, twenty have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $289.45.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.60 by $0.13. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The firm had revenue of $60.30 billion during the quarter, compared to the consensus estimate of $59.72 billion. During the same period last year, the business posted $3.04 EPS. The business’s revenue was up 9.2% compared to the same quarter last year.
Several institutional investors have recently bought and sold shares of UNH. Oregon Public Employees Retirement Fund lifted its position in shares of UnitedHealth Group by 50,446.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock worth $214,000 after buying an additional 53,244,249 shares in the last quarter. Capital International Investors increased its stake in shares of UnitedHealth Group by 223.0% during the 3rd quarter. Capital International Investors now owns 16,319,843 shares of the healthcare conglomerate’s stock worth $4,341,731,000 after purchasing an additional 11,267,910 shares during the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $2,343,175,000. BlackRock Inc. increased its stake in shares of UnitedHealth Group by 3.1% during the 4th quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock worth $17,396,391,000 after purchasing an additional 2,123,417 shares during the last quarter. Finally, Rehmann Capital Advisory Group increased its stake in shares of UnitedHealth Group by 26,088.2% during the 3rd quarter. Rehmann Capital Advisory Group now owns 1,723,185 shares of the healthcare conglomerate’s stock worth $6,477,000 after purchasing an additional 1,716,605 shares during the last quarter. 86.68% of the stock is currently owned by hedge funds and other institutional investors.
In other UnitedHealth Group news, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, January 22nd. The shares were sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the transaction, the director now owns 77,702 shares of the company’s stock, valued at approximately $20,716,130.22. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Gail R. Wilensky sold 2,930 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the transaction, the director now directly owns 64,726 shares in the company, valued at approximately $16,400,921.14. The disclosure for this sale can be found here. In the last three months, insiders have sold 17,930 shares of company stock worth $4,587,133. Insiders own 0.87% of the company’s stock.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $0.90 dividend. The ex-dividend date was Friday, March 8th. This represents a $3.60 annualized dividend and a yield of 1.66%. UnitedHealth Group’s payout ratio is 27.95%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: NASDAQ Stock Market Explained
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.